SCHEMBL7003153

SCHEMBL7003153

COC(=O)c1nn(CCN2CCOCC2)c(C(=O)O)c1N

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 6/20 0.40
KDM4E B2RXH2 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 2/20 0.40
HPGD P15428 2/20 0.40
GLA P06280 1/20 0.40
CNR2 P34972 3/20 0.40
MAPK1 P28482 1/20 0.39
POLB P06746 2/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 2/20 0.37
CNR1 P21554 2/20 0.37
ATM Q13315 1/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7003147 0.93 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7001420 0.82 GAA (0.47) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7001412 0.77 GAA (0.49) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL13093837 0.75 PKM (0.37) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7002042 0.72 LMNA (0.39) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL6993863 0.69 CYP1A2 (0.49) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL331349 0.69 ALDH1A1 (0.36) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL6807697 0.68 CCNA2 (0.37) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL6999211 0.68 CYP1A2 (0.48) SMN1; SMN2ALDH1A1MEN1KMT2AGAA
SCHEMBL20670974 0.68 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123296-B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LTD (GB) 2003-09-17 EP disclosed
US-6333330-B1 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. 2001-12-25 US disclosed
EP-1123296-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION Pfizer Limited (GB) 2001-08-16 EP disclosed
WO-2000024745-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LIMITED (GB) 2000-05-04 WO disclosed